Sanofi dominates the market for therapies that treat Pompe disease, a rare enzyme deficiency. The FDA has approved an Amicus Therapeutics combination treatment for patients inadequately served by the Sanofi products.
The post Amicus Therapeutics Rare Disease Combo Therapy Wins Long-Awaited FDA Nod appeared first on Above the Law.
CAR T-therapies for cancer are now under tighter FDA scrutiny as the agency opens an inquiry regarding reports that some patients who received these cell…
Formed by Baidu founder and CEO Robin Li, BioMap uses artificial intelligence technology to glean insight into proteins to guide biologic drug discovery. The startup…
During a physician’s career, they are likely to experience a medical malpractice lawsuit. In 2022, the American Medical Association reported that 31.2% of physicians had…
By guest blogger Lisa Ramsey, Professor of Law, University of San Diego School of Law The Supreme Court will likely hold in Elster that Section…
For those of you who follow my column, you may have noticed that I tend to focus on things that are wrong. There is never…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
Responses